http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0858807-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1fd34fea6801ea1d9286475b96be2d26
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-685
filingDate 1997-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_399161ed6d6bf354d6ad25e345584663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46b3f35164e637c2e66dba29d5709ece
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4eb711f1dd9db3b0f0bb979a42ffbf37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c093797d534d16f7f3b1e973e475d57
publicationDate 1999-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0858807-A3
titleOfInvention Use of dopamine receptor antagonists in palliative tumor therapy
abstract The side effect caused by alkylphosphocholines like miltefosinenBody weight loss can be caused by certain antagonists such as domperidone andnPimozide can be antagonized. It is important that the combination ofnAlkylphosphocholine plus antidote has no influence on the antitumor effect of thenAlkylphosphocholines. The combination also did not create any new onesnSide effects in the animals.
priorityDate 1996-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0855397-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9705129-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4707484-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87063904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399686
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11535903
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226447063
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87063903
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226447064
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226447062

Total number of triples: 36.